Johnson & Johnson's Ethicon Ordered to Pay $76.56 Million in Breach of Contract Case Involving AI Surgical Imaging Firm ChemImage

Jul 11, 2025 10:30 CST Updated 10:30

Johnson & Johnson

Medical Device R&D and Manufacturer

ChemImage

A research company providing chemical and biological application software

According to overseas reports, Johnson & Johnson in one caseLost the lawsuit for breach of contract. In May this yearUnited States District Court for the Southern District of New YorkJohnson & Johnson (Ethicon) was found to be in breach of contract,Therefore, the judgeJesse M. FurmanThe verdict was officially issued this week.CourtJudgment on Johnson & Johnson (Ethicon to Pay ChemImage $76.56 Million in Compensation.

Court Judgment$76.56 millionThe compensation includes two parts: one part is$40 million contract fee, and the other part is$37 million in compensation (including intellectual property impairment compensation). Among themDeduct the $510,000 that both parties confirmed ChemImage has obtained through asset sales.

Introduction to ChemImage

ChemImage is an innovative medical device company dedicated to making the world healthier and safer through significant breakthroughs in chemical imaging technology.It is developing an AI-driven software that allows surgeons to "visualize" and interpret the movements of robotic surgical tools. These images will assist surgeons in real-time assessment of damaged or cancerous tissues.

Background of the Dispute

Facing increasingly fierce market competition in surgical robots, especially needing to faceIntuitive, this behemoth. Johnson & Johnson needs to add innovative selling points for its surgical robot, so in 2019, it...ChemImage Corporation has reached a cooperation agreement and signedContracts worth billions of dollars.

After signing the contract, Johnson & JohnsonChemImage prepaid $7 million. Subsequently, both parties began to accelerate the promotion of cooperation, but unfortunately, the project progress did not go as hoped.By early 2023, Johnson & Johnson found that the integration of ChemImage software with robotic technology had not met expectations (the project was severely delayed), and Johnson & Johnson believed that a commercially viable product was not in sight, leading to the breakdown of the collaboration between the two parties.

InMarch 6, 2023, Johnson & JohnsonTerminating the contract on the grounds of "unfinished nodes," butChemImage does not recognize this. Therefore, ChemImage accused Johnson & Johnson of breach of contract and filed a lawsuit against Johnson & Johnson for tortious interference with contract. Both parties are striving to present evidence favorable to their respective sides.

Johnson & Johnson Loses Lawsuit, but It’s Unclear Whether They Will Appeal; After Spending Hundreds of Millions, Now Facing Nearly $80 Million in Compensation, Reluctance Remains.